PACT AI
AboutBlogContact
Sign Up / Log In
© 2026 PACT AI. All rights reserved.
TikTokInstagram
AboutContactPrivacyHealth PrivacyTerms

Blog

Find the latest news and information on brain cancer from the PACT team

If my tumor isn't shrinking, does that mean the treatment isn't working?

4/2/2026

In brain cancer trials, success isn't always measured by tumor shrinkage. Stability, survival, and quality of life can also define meaningful benefit.

Navigating Insurance for a Brain Cancer Trial

4/1/2026

Confused about what insurance covers in a brain cancer clinical trial? This guide breaks down routine costs, research costs, and how to get answers fast.

What are clinical trial eligibility criteria?

3/31/2026

What are phases in brain cancer clinical trials?

3/26/2026

Why is imaging so central to brain cancer clinical trials?

3/24/2026

What are the signs and symptoms of a brain tumor?

3/19/2026

Brain tumor symptoms vary depending on where the tumor is located. Here's what patients and caregivers commonly report — and when to talk to a doctor.

Why do brain cancer patients respond to treatment differently?

3/19/2026

How can I Advocate for Myself as a Brain Cancer Patient?

3/18/2026

Learn how to advocate for yourself as a brain cancer patient. From asking the right questions to requesting second opinions and navigating clinical trials.

Why do I qualify for different trials than someone with the same diagnosis?

3/17/2026

What is GBM Agile?

3/16/2026

GBM AGILE (NCT03970447) is an actively enrolling Phase 2/3 glioblastoma clinical trial testing multiple therapies at 62 sites. Here's what patients need to know.

Glioblastoma Treatment 2026–2030: Targets, Modalities, and Pipeline Overview

3/13/2026

Why does timing matter in brain cancer treatment decisions?

3/12/2026

What is informed consent in clinical trials?

3/11/2026

What is informed consent in a clinical trial? A plain-language guide for GBM patients and caregivers on what to expect before you sign.

How does trial design change when therapies must reach the brain?

3/10/2026

Brain cancer trials are designed differently because therapies must cross the blood–brain barrier. Here's how delivery challenges shape modern trial design.

A Phase 3 GBM Trial for MGMT Unmethylated Patients

3/9/2026

The Gliofocus trial (NCT06388733) is enrolling newly diagnosed MGMT unmethylated glioblastoma patients at 93 sites across the US and globally.

What can I expect after brain tumor surgery?

3/5/2026

Brain tumor surgery is often just the first step. Here's what happens after surgery and how results guide next steps in treatment and clinical trials.

How can I manage traveling for a brain cancer clinical trial?

3/4/2026

Learn how to manage travel logistics for a brain cancer clinical trial, from covering costs to planning visit, so distance doesn't stand in your way.

Why won't cancer drugs reach my brain tumor?

3/3/2026

What 'molecular subtype' mean in brain cancer?

2/26/2026

What is the blood-brain barrier?

2/24/2026

Why is brain cancer in grades instead of stages?

2/19/2026

What is next-generation sequencing and why does it matter?

2/17/2026

Why do biomarkers matter in brain cancer?

2/10/2026

What Makes the Brain's Environment Unique for Cancer Research?

12/5/2025

What Are Cancer Vaccines? How Do They Work Against Tumors?

12/5/2025

How Do Genes and Mutations Influence Brain Tumor Behavior?

12/5/2025

Tumor mutations shape how brain cancers grow, spread, and respond to treatment. Here's why genetic changes matter — and how they guide today's clinical trials.

What Is Immunotherapy? Should I Consider It for Brain Cancer?

12/5/2025

What Are Oncolytic Viruses — and How Do They Fight Tumors?

12/5/2025

Oncolytic viruses are specially engineered viruses that infect and destroy cancer cells while activating the immune system. Here's how they work — and what makes them promising in brain cancer research.

PACT AI x Gray for Glioblastoma: A Partnership Built for Patients and Caregivers

12/5/2025

PACT AI and Gray for Glioblastoma are joining forces to expand support, awareness, and access to clinical trial options for the glioblastoma community.

How does Modern Radiation Therapy target Brain Tumors With Precision?

12/5/2025

What Are Targeted Therapies — and How Do They Differ from Chemotherapy?

12/5/2025

What are Tumor Treating Fields (TTF)?

11/16/2025

What Is Chemotherapy?

11/12/2025